Data as of Nov 26
| +0.11 / +0.44%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 35.00, with a high estimate of 37.00 and a low estimate of 30.00. The median estimate represents a +40.22% increase from the last price of 24.96.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.